Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
暂无分享,去创建一个
D. Neuberg | G. Weber | J. Zwicker | E. Uhlmann | F. Campigotto | J. Donato | Erika Coletti | Erik J. Uhlmann
[1] C. Flowers,et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Wen,et al. Medical management of brain tumors and the sequelae of treatment. , 2015, Neuro-oncology.
[3] S. Noble,et al. Heparins and cancer survival: where do we stand? , 2014, Thrombosis research.
[4] Shengdi Chen,et al. Volume Quantification of Acute Infratentorial Hemorrhage with Computed Tomography: Validation of the Formula 1/2ABC and 2/3SH , 2013, PloS one.
[5] S. Patel,et al. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases , 2012, Melanoma research.
[6] D. Neuberg,et al. Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier , 2012, Journal of thrombosis and haemostasis : JTH.
[7] E. Sessa,et al. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: A case series study , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[8] Griffin M. Weber,et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) , 2010, J. Am. Medical Informatics Assoc..
[9] D Bergqvist,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.
[10] Lei Feng,et al. Risk of Intracranial Hemorrhage and Cerebrovascular Accidents in Non-small Cell Lung Cancer Brain Metastasis Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] A. Kakkar. Venous thromboembolism prophylaxis and treatment in patients with cancer. , 2008, Clinical advances in hematology & oncology : H&O.
[12] D. Gerber,et al. Management of venous thromboembolism in patients with primary and metastatic brain tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] 高橋 聡,et al. Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .
[14] H. Chew,et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. , 2006, Archives of internal medicine.
[15] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.
[16] S. Turazzi,et al. Bleeding cerebral neoplasms with symptomatic hematoma. , 2003, Journal of neurosurgical sciences.
[17] M. Prins,et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.
[18] B. Norrving,et al. Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study , 2001, Stroke.
[19] J. Olsen,et al. Prognosis of cancers associated with venous thromboembolism. , 2000, The New England journal of medicine.
[20] L. Deangelis,et al. Therapy of venous thromboembolism in patients with brain metastases , 1994, Cancer.
[21] J. Broderick,et al. Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.
[22] L. R. Caplan,et al. Intracerebral haemorrhage , 1992, The Lancet.
[23] D. Kondziolka,et al. Significance of hemorrhage into brain tumors: clinicopathological study. , 1987, Journal of neurosurgery.